288.73
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $288.73, with a volume of 2.66M.
It is up +0.96% in the last 24 hours and down -24.32% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$285.98
Open:
$284.5
24h Volume:
2.66M
Relative Volume:
1.27
Market Cap:
$65.02B
Revenue:
$189.25B
Net Income/Loss:
$5.36B
P/E Ratio:
12.29
EPS:
23.5
Net Cash Flow:
$5.34B
1W Performance:
+2.49%
1M Performance:
-24.32%
6M Performance:
-27.87%
1Y Performance:
-45.51%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ELV
Elevance Health Inc
|
288.73 | 64.40B | 189.25B | 5.36B | 5.34B | 23.50 |
![]()
UNH
Unitedhealth Group Inc
|
261.07 | 255.92B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
CI
Cigna Group
|
292.17 | 78.11B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
CVS
Cvs Health Corp
|
60.00 | 75.45B | 378.96B | 5.28B | 5.94B | 4.19 |
![]()
HUM
Humana Inc
|
232.62 | 27.94B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-21-25 | Downgrade | Argus | Buy → Hold |
Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mar-17-25 | Upgrade | Argus | Hold → Buy |
Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
Oct-18-24 | Downgrade | Argus | Buy → Hold |
Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
Jun-24-24 | Initiated | Morgan Stanley | Overweight |
May-30-24 | Initiated | Robert W. Baird | Outperform |
Mar-06-24 | Initiated | Barclays | Overweight |
Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
Positive Sentiment Still Eludes Elevance Health, Inc. (NYSE:ELV) Following 25% Share Price Slump - simplywall.st
Does Elevance Health (NYSE:ELV) Have A Healthy Balance Sheet? - Yahoo Finance
Elevance Health Board Appoints Steve Collis As Director - citybiz
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs - MSN
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence - The Globe and Mail
Elevance Health (ELV) Receives Buy Rating from UBS with Optimistic EPS Forecast - GuruFocus
Elevance Health, Inc: A Deeply Undervalued Long-Term OpportunityF.A.S.T. GraphsCommentaries - Advisor Perspectives
What makes Elevance Health Inc. stock price move sharplyFree Stock Review For Consistent Profits - jammulinksnews.com
When is Elevance Health Inc. stock expected to show significant growthRapid market gains - jammulinksnews.com
Indiana Chamber Ends Partnership With Anthem, Cites Negotiation Breakdown - InkFreeNews.com
Centene's First Quarterly Loss In 13 Years Sends Shares Crashing - Benzinga
Elevance Health Inc. Stock Analysis and ForecastHigh-yield trading alerts - PrintWeekIndia
Elevance Health (ELV) Analyst Rating Update: Price Target Adjusted | ELV Stock News - GuruFocus
Elevance Health (ELV) Target Price Adjusted Amid Market Concerns - GuruFocus
Elevance Health (ELV) Target Price Adjusted Amid Market Concerns | ELV Stock News - GuruFocus
What drives Elevance Health Inc. stock priceFree High-Return Strategy Alerts - PrintWeekIndia
Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty - Yahoo Finance
Is Elevance Health Inc. stock a growth or value playConsistent high-yield stocks - jammulinksnews.com
UnitedHealth, Anthem, Cigna unveil what small employers might pay for 2026 health coverage - BenefitsPRO
Molina Healthcare Stumbles; Cigna, CVS And Humana Go With ItMolina Healthcare (NYSE:MOH) - Benzinga
Elevance Health's Strategic Acquisition of CareBridge: Accelerating Carelon's Dominance in Value-Based, Home-Based Care - AInvest
Elevance Health: CEO Buys As CareBridge Drives Strong Growth - Seeking Alpha
Elevance Health (NYSE:ELV) stock falls 14% in past week as one-year earnings and shareholder returns continue downward trend - Yahoo Finance
Is Elevance Health Inc. a good long term investmentAccelerated earnings growth - Autocar Professional
Elevance Health, Inc. (ELV): I Won’t Touch It With A 10 Foot Pole, Says Jim Cramer - MSN
What analysts say about Elevance Health Inc. stockBreakout stock performance - jammulinksnews.com
ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, - GlobeNewswire
Indiana Chamber will no longer have Anthem as provider for small-business health coverage - Inside INdiana Business
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know - TradingView
Elevance Health Named Top Dividend Stock With Insider Buying and 2.43% Yield (ELV) - Nasdaq
Oscar Health sees full-year loss as ACA market troubles spread - Modern Healthcare
Breakthrough: Apple Watch-Based Asthma Program Shows Major Success in Nationwide Clinical Trial - Stock Titan
Barclays Adjusts Elevance Health (ELV) Price Target After Earnin - GuruFocus
UBS Lowered Firm’s PT on Elevance Health (ELV), Kept a Buy Rating - MSN
Lobbying Update: $1,380,000 of ELEVANCE HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Ken Griffin, Neville Shah, Sage Capital, Elevance Health Inc (ELV), NVIDIA Corp (NVDA), and More - Insider Monkey
Elevance Health downgraded at Argus on profit margin pressure - MSN
Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings - MSN
Elevance Health stock hits 52-week low at 275.6 USD - Investing.com
Elevance Health (ELV) Nosedives 12% on Disappointing Q2 - MSN
Elevance Health: Navigating the Perfect Storm in U.S. Health Insurance - AInvest
Elevance Health: the big hit - MarketScreener
Gail Boudreaux Bought 6.0% More Shares In Elevance Health - simplywall.st
Elevance Health, Inc.'s (NYSE:ELV) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):